[Synergic effect of Dextran 70 at 32% and an antibiotic in the prevention of peritoneal adhesions. Experimental study in rats]. 1992

O Boudouris, and M Autret, and F X Paris, and I Karaïtianos, and D Loisance, and J Henry-Suchet
Service de Chirurgie, Hôpital Pierre Rouqués, Paris.

In an experimental study we evaluate the anti-adherential effect of four different solutions: physiological serum, Chloramphenicol, Dextran 70 (32%) and the association of these last two solutions. Synergic effect is shown when using an antibiotic (Chloramphenicol) with a non-bactericid solution (Dextran). Comparing our results with current literature, we are confident on the efficacity of similar association concerning other solutions than Dextran 70 (32%).

UI MeSH Term Description Entries
D010532 Peritoneal Diseases Pathological processes involving the PERITONEUM. Peritoneal Disease
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002429 Cecal Diseases Pathological developments in the CECUM. Cecal Disease,Disease, Cecal,Diseases, Cecal
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D003911 Dextrans A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes. Dextran,Dextran 40,Dextran 40000,Dextran 70,Dextran 75,Dextran 80,Dextran B-1355,Dextran B-1355-S,Dextran B1355,Dextran B512,Dextran Derivatives,Dextran M 70,Dextran T 70,Dextran T-40,Dextran T-500,Hemodex,Hyskon,Infukoll,Macrodex,Polyglucin,Promit,Rheodextran,Rheoisodex,Rheomacrodex,Rheopolyglucin,Rondex,Saviosol,Dextran B 1355,Dextran B 1355 S,Dextran T 40,Dextran T 500
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D000267 Tissue Adhesions Pathological processes consisting of the union of the opposing surfaces of a wound. Adhesions, Tissue,Surgery-Induced Tissue Adhesions,Surgical Adhesions,Adhesion, Surgery-Induced Tissue,Adhesion, Surgical,Adhesion, Tissue,Adhesions, Surgery-Induced Tissue,Adhesions, Surgical,Surgery Induced Tissue Adhesions,Surgery-Induced Tissue Adhesion,Surgical Adhesion,Tissue Adhesion,Tissue Adhesion, Surgery-Induced,Tissue Adhesions, Surgery-Induced

Related Publications

O Boudouris, and M Autret, and F X Paris, and I Karaïtianos, and D Loisance, and J Henry-Suchet
April 1978, Fertility and sterility,
O Boudouris, and M Autret, and F X Paris, and I Karaïtianos, and D Loisance, and J Henry-Suchet
February 1964, Archives of surgery (Chicago, Ill. : 1960),
O Boudouris, and M Autret, and F X Paris, and I Karaïtianos, and D Loisance, and J Henry-Suchet
January 1967, Israel journal of medical sciences,
O Boudouris, and M Autret, and F X Paris, and I Karaïtianos, and D Loisance, and J Henry-Suchet
November 1991, Obstetrics and gynecology,
O Boudouris, and M Autret, and F X Paris, and I Karaïtianos, and D Loisance, and J Henry-Suchet
June 1984, The Annals of thoracic surgery,
O Boudouris, and M Autret, and F X Paris, and I Karaïtianos, and D Loisance, and J Henry-Suchet
March 1940, Annals of surgery,
O Boudouris, and M Autret, and F X Paris, and I Karaïtianos, and D Loisance, and J Henry-Suchet
January 1988, International journal of fertility,
O Boudouris, and M Autret, and F X Paris, and I Karaïtianos, and D Loisance, and J Henry-Suchet
October 1961, Nagasaki Igakkai zasshi = Nagasaki medical journal,
O Boudouris, and M Autret, and F X Paris, and I Karaïtianos, and D Loisance, and J Henry-Suchet
October 1966, Igaku kenkyu. Acta medica,
O Boudouris, and M Autret, and F X Paris, and I Karaïtianos, and D Loisance, and J Henry-Suchet
January 1976, Acta obstetricia et gynecologica Scandinavica,
Copied contents to your clipboard!